Wern H. Ng
Gold Coast, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cracking the code: ET-1 signaling unlocks new therapies for virus-induced osteoarthritis.
Journal: Npj viruses
Published: September 29, 2024
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants.
Journal: Nature communications
Published: May 06, 2024
Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives.
Journal: QJM : monthly journal of the Association of Physicians
Published: January 30, 2024
FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
Journal: Nature communications
Published: July 13, 2023
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
Journal: PLoS pathogens
Published: September 21, 2022
Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2.
Journal: British journal of pharmacology
Published: June 06, 2022
Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation.
Journal: Nature communications
Published: May 03, 2022
TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF)-Dependent Antiviral Responses Protect Mice against Ross River Virus Disease.
Journal: mBio
Published: January 28, 2022
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
Journal: mBio
Published: February 10, 2021
Last Updated: 09/26/2026